SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System
SS Innovations (NASDAQ:SSII) has achieved a groundbreaking milestone by completing the world's first robotic telesurgery for weight loss using their SSi Mantra 3 surgical robotic system. The surgery was performed by Dr. Mohit Bhandari from a distance of 560 miles, connecting SS Innovations' headquarters in Gurugram to Mohak Bariatric & Robotic Surgery Centre in Indore, India.
Two One-Anastomosis Gastric Bypass (OAGB) procedures were successfully executed with zero perceptible lag and flawless precision. The achievement demonstrates the system's capability to deliver advanced surgical care to remote locations, potentially revolutionizing healthcare accessibility and affordability globally.
SS Innovations (NASDAQ:SSII) ha raggiunto un traguardo rivoluzionario completando la prima telesurgia robotica al mondo per la perdita di peso utilizzando il loro SSi Mantra 3 sistema robotico chirurgico. L'intervento è stato eseguito dal dott. Mohit Bhandari a una distanza di 560 miglia, collegando la sede di SS Innovations a Gurugram con il Mohak Bariatric & Robotic Surgery Centre a Indore, India.
Due procedure di One-Anastomosis Gastric Bypass (OAGB) sono state eseguite con successo senza alcun ritardo percepibile e con precisione impeccabile. Questo risultato dimostra la capacità del sistema di fornire cure chirurgiche avanzate in luoghi remoti, potenzialmente rivoluzionando l'accessibilità e l'economicità dell'assistenza sanitaria a livello globale.
SS Innovations (NASDAQ:SSII) ha alcanzado un hito innovador al completar la primera telescirugía robótica del mundo para la pérdida de peso utilizando su sistema quirúrgico robótico SSi Mantra 3. La cirugía fue realizada por el Dr. Mohit Bhandari desde una distancia de 560 millas, conectando la sede de SS Innovations en Gurugram con el Mohak Bariatric & Robotic Surgery Centre en Indore, India.
Se realizaron con éxito dos procedimientos de Bypass Gástrico de Una Anastomosis (OAGB) sin retraso perceptible y con una precisión impecable. Este logro demuestra la capacidad del sistema para brindar atención quirúrgica avanzada en ubicaciones remotas, lo que podría revolucionar la accesibilidad y asequibilidad de la atención médica a nivel mundial.
SS Innovations (NASDAQ:SSII)� SSi Mantra 3 수술 로봇 시스�� 이용하여 세계 최초� 체중 감량� 위한 로봇 원격 수술� 성공적으� 완료하 획기적인 성과� 달성했습니다. 수술은 모힛 반다� 박사갶 560마일 떨어� 거리에서 수행했으�, SS Innovations� 구루그람 본사와 인도 인도르의 Mohak 비만 � 로봇 수술 센터� 연결했습니다.
� 건의 단일 문합 위우회술 (OAGB)� 지� 없이 완벽� 정밀도로 성공적으� 수행되었습니�. 이번 성과� 첨단 수술 치료� 원격지에서� 제공� � 있 시스템의 능력� 입증하며, � 세계적으� 의료 접근성과 경제성을 혁신� 잠재력을 보여줍니�.
SS Innovations (NASDAQ:SSII) a franchi une étape majeure en réalisant la première téléchirurgie robotisée au monde pour la perte de poids grâce à leur système robotique chirurgical SSi Mantra 3. L’intervention a été effectuée par le Dr Mohit Bhandari à une distance de 560 miles, reliant le siège de SS Innovations à Gurugram au Mohak Bariatric & Robotic Surgery Centre à Indore, en Inde.
Deux procédures de Bypass gastrique à une anastomose (OAGB) ont été réalisées avec succès, sans aucun décalage perceptible et avec une précision parfaite. Cette réussite démontre la capacité du système à fournir des soins chirurgicaux avancés dans des zones éloignées, ce qui pourrait révolutionner l’accessibilité et l’abordabilité des soins de santé à l’échelle mondiale.
SS Innovations (NASDAQ:SSII) hat einen bahnbrechenden Meilenstein erreicht, indem es die weltweit erste robotergestützte Teleskopchirurgie zur Gewichtsreduktion mit ihrem SSi Mantra 3 chirurgischen Robotersystem durchgeführt hat. Die Operation wurde von Dr. Mohit Bhandari aus einer Entfernung von 560 Meilen durchgeführt, wobei der Hauptsitz von SS Innovations in Gurugram mit dem Mohak Bariatric & Robotic Surgery Centre in Indore, Indien, verbunden wurde.
Zwei One-Anastomosis Magenbypass (OAGB)-Verfahren wurden erfolgreich mit null wahrnehmbarer Verzögerung und makelloser Präzision durchgeführt. Diese Leistung zeigt die Fähigkeit des Systems, fortschrittliche chirurgische Versorgung an entfernte Orte zu bringen und könnte die Zugänglichkeit und Erschwinglichkeit der Gesundheitsversorgung weltweit revolutionieren.
- First-ever successful robotic telesurgery for weight loss performed at 560 miles distance
- Zero perceptible lag and flawless precision achieved during the remote procedures
- Technology enables access to specialized surgical care in remote and underserved areas
- System demonstrates potential for reducing healthcare access barriers and patient travel needs
- None.
Insights
SS Innovations achieves groundbreaking robotic telesurgery milestone, demonstrating significant technological capabilities with potential market expansion implications.
This successful demonstration of the SSi Mantra 3 surgical robotic system represents a significant technological achievement in the medical robotics field. Completing a complex bariatric procedure across 560 miles with reportedly zero perceptible lag addresses one of telesurgery's fundamental challenges � latency issues that typically compromise surgical precision.
The successful execution of One-Anastomosis Gastric Bypass (OAGB) procedures, which require meticulous control and precision, demonstrates the system's advanced capabilities. This particular procedure involves both resection and anastomosis � technically demanding maneuvers that test the limits of remote robotic control systems.
From a market perspective, this advancement positions SS Innovations to potentially capture market share in both the robotic surgery segment and the emerging telemedicine infrastructure market. The ability to perform complex surgeries remotely has profound implications for healthcare delivery models, particularly in regions with geographic barriers to specialized surgical expertise.
What distinguishes this achievement is the practical demonstration of remote surgical capabilities in a real clinical setting rather than a controlled laboratory environment. While other companies have demonstrated remote surgical capabilities, applying this technology to weight loss surgery � a high-volume procedure worldwide � suggests a strategic focus on commercially viable applications rather than merely technological proof-of-concepts.
The technology potentially addresses a critical healthcare disparity by enabling expert surgical care delivery to underserved regions, which may align with both commercial growth opportunities and regulatory favor in developing healthcare markets.
- Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric & Robotic Surgery Centre in Indore, India.
- Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system.
FORT LAUDERDALE, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- (the “Company� or “SS Innovations�) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the world’s first robotic telesurgery for weight loss utilizing the Company’s advanced SSi Mantra 3 surgical robotic system.
This landmark bariatric telesurgery bridged a distance of 560 miles between SS Innovations' headquarters in Gurugram, India and the Mohak Bariatric & Robotic Surgery Centre in Indore, India. Despite the vast distance, the surgery was performed with zero perceptible lag, flawless precision, and seamless robotic control, setting a new global benchmark for remote surgery capabilities.
The procedures involved two One-Anastomosis Gastric Bypass (OAGB) surgeries, an advanced form of bariatric surgery that reduces stomach size and reroutes the digestive tract to support long-term weight loss and improve metabolic health. The robotic procedures were successfully performed by Dr. Mohit Bhandari, a renowned bariatric surgeon, President of IRCAD India, and Founder & Director of Mohak Bariatric & Robotic Surgery Centre, Indore. Operating from Gurugram, Dr. Bhandari remotely led his Indore-based surgical team, which provided on-site assistance, ensuring expert execution and clinical excellence throughout.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We view this as an additional defining moment for the future of global healthcare. With robotic telesurgery powered by SSi Mantra, we are bridging healthcare gaps and ensuring that world-class surgical expertise reaches even the most remote regions. By successfully performing surgeries across borders, we have shown that distance is no longer a barrier to advanced medical care. We are not just pushing technological boundaries; we are fulfilling our mission to democratize robotic surgery. Telesurgery is revolutionizing healthcare by eliminating the need for patients to travel, making advanced surgical care truly accessible and affordable.�
Dr. Bhandari added, “With the SSi Mantra 3, we have not only demonstrated the immense potential of robotic telesurgery but also redefined the boundaries of surgical care. Performing the world’s first robotic telesurgery for weight loss is a moment of immense professional pride. This milestone represents a bold new paradigm for access, equity, and excellence in healthcare.�
SS Innovations is leading the charge in revolutionizing surgical care through cutting-edge technology and a strong humanitarian vision, with robotic telesurgeries utilizing SSi Mantra now taking place across hundreds of miles, including in remote and underserved areas. As the Company continues to refine its technology, the focus remains on practical solutions that enhance surgical efficiency, democratize access to specialized care, and improve patient outcomes across India and beyond.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra� surgical robotic system and its comprehensive suite of “SSi Mudra� surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at or for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward-Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,� “assume,� “believe,� “estimate,� “expect,� “will,� “intend,� “may,� “plan,� “project,� “should,� “could,� “seek,� “designed,� “potential,� “forecast,� “target,� “objective,� “goal,� or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations� future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
Devin Sullivan, Managing Director
T: (212) 836-9608
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
